Navigation Links
Sihuan Pharmaceutical Announces 2013 Interim Results
Date:8/26/2013

, respectively. Meanwhile, the Company's established products such as Chuanqing, Qu'Ao, Qingtong and GM1 recorded steady sales growth on the back of deepened market penetration, especially into low-end markets.

Non-CCV Products

The increasingly fierce price competition in the Chinese market of non-exclusive products led to relatively lower sales volume of the Company's non-CCV products, which are predominantly non-exclusive drugs. Nevertheless, sales of and Zhuo'Ao increased by 59.1% and 21.8% respectively.

Clear sales and marketing strategies achieved positive resultsDuring the Period, the Company stepped up its academic promotion work as well as boosted incentives to distributors for Kelinao and Oudimei, thereby encouraging more frequent promotion of our products and increasing clinical use. In the meantime, the company speeded up market penetration of Oudimei by provincial tender wins and supplementary tender submissions in provinces where tenders were delayed. As a result, the Company successfully accelerated the sales rebound of Kelinao and Oudimei. On the other hand, the Company achieved satisfying results through appropriate tender strategies for each product, depending on competitiveness of their markets and their level of maturity in different markets. For products at earlier stages of development and are exclusive or have fewer competitors, the Company expanded market coverage by provincial tender wins and supplementary tender submissions in provinces where tenders were delayed. For non-exclusive products, the Company strategically expanded its access to low-end markets with EDL ("Essential Drug List") tender wins and participation in the rural cooperative medical scheme.

New products development enter into the harvest periodSince Xuanzhu Pharma Co., Ltd. becoming a wholly-owned subsidiary of the Company in 2012, the Company achieved a number of breakthroughs by leveraging its effective resources integration. To date, th
'/>"/>

SOURCE Sihuan Pharmaceutical Holdings Group Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Sihuan Pharmaceutical Secures SFDA Approval for Anaprazole Sodium Category 1.1 New Drug Clinical Studies
2. Sihuan Pharmaceutical Announces 2012 Annual Results
3. State Food and Drug Administration Grants Approval to Sihuan Pharmaceutical for Clinical Trial of Innovative Drug -- Pinoxacin Hydrochloride
4. Sihuan Pharmaceutical Collaborates with NeuroVive to Develop Two Innovative Cardio-cerebral Vascular Products in China
5. Sihuans First-to-market Generic Drug Roxatidine Receives New Drug Certificate and Approval for Production
6. Sihuan Pharmaceutical Announces 2012 Interim Results
7. Sihuans First-to-market Generic Drug Roxatidine Passes On-site Inspection for Drug Registration Conducted by the Chinese State Food and Drug Administration
8. Immune Pharmaceuticals Completes Merger with EpiCept Corporation
9. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
10. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
11. Par Pharmaceutical Receives Approval of sANDA for Bupropion Hydrochloride Extended-Release Tablets USP (XL), 300 mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... Conn. , Sept. 19, 2014 UBM ... , a leading online community to help oncologists and ... information available regarding the use of targeted therapies and ... cancer research and treatment.  Every September, ... a way to raise awareness about blood cancers—helping to ...
(Date:9/19/2014)... -- According to market research report, ... & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, Surgical Procedure, ... Geography - Global Trends & Forecast to 2019", ... market on the basis of various types, applications, ... market size of each of these segments in ...
(Date:9/19/2014)... DIEGO , Sept. 19, 2014  Lpath, ... leader in bioactive lipid-targeted therapeutics, announced today that ... 3,605,042 registered shares of common stock and 3,605,042 ... combined purchase price for one registered share of ... one unregistered share of common stock will be ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3Lpath, Inc. Announces $12.5 Million Registered Direct Offering 2Lpath, Inc. Announces $12.5 Million Registered Direct Offering 3
... NEW YORK, Nov. 10 Reportlinker.com announces that ... in its catalogue. , Infections ... http://www.reportlinker.com/p0161914/Infections-Ear-Infections.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire , Life Science Analytics, ... the current drug pipeline. This report provides ...
... JumpStart Inc., the Northeast Ohio venture development ... early-stage businesses, announced a JumpStart Ventures investment commitment ... of NDI Medical, the Highland Hills, OH medical ... handheld disposable nerve stimulator. , (Logo: ...
Cached Medicine Technology:Reportlinker Adds Infections Ear Infections 2Reportlinker Adds Infections Ear Infections 3JumpStart Invests in Checkpoint Surgical 2JumpStart Invests in Checkpoint Surgical 3
(Date:9/19/2014)... made from the wonder material graphene has been used ... developing cancer. , The biosensor has been shown ... bioassay tests currently in use, and was able to ... the possibility of a rapid, point-of-care diagnostic tool for ... September, in IOP Publishing,s journal 2D Materials . ...
(Date:9/19/2014)... September 19, 2014 Follow ... assays used for detection and quantification of the ... sample. Driven by steady expansion in immunodiagnostics and ... global immunoassay systems market has evolved remarkably well ... such as diabetes, cardio-vascular ailments, infectious diseases, allergy ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Recent ... freight trucking industry increased their sales by 7% in ... from the trucking industry can be used as a ... as a whole. This data has been proven to ... forms of freight transportation. Other non-trucking data is largely ...
(Date:9/19/2014)... Follow us on LinkedIn ... and immunosuppressant drugs to prevent rejection, organ transplantation ... diseases related to the heart, kidneys, lungs, pancreas, ... have phenomenally revolutionized the survival rate of terminal ... a pivotal medical intervention for thousands of patients ...
(Date:9/19/2014)... of the QUT Centre for Accident Research & Road ... the Occupational Safety in Transport Conference (OSIT) which is ... , Dr Ross Blackman, a CARRS-Q road safety researcher, ... when reduced speed limits and related traffic controls remained ... as crying wolf. If people are asked to slow ...
Breaking Medicine News(10 mins):Health News:Graphene sensor tracks down cancer biomarkers 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 2Health News:LeaseQ Announces Good News For The Truck Leasing Industry As Truck Rentals In The U.S Continues to Gain Traction 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Number of Terminally Ill Patients Drive the Global Organ and Tissue Transplantation Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Don't cry wolf: Drivers fed up with slowing down at inactive roadwork sites 2
... Health Plans Move Closer to Cutting AmerisourceBergen-Brand,Pharmacies ... WASHINGTON, Feb. 28 AmerisourceBergen (NYSE:,ABC) warehouse ... hundreds of,their fellow Teamsters outside ABC,s annual ... a warning to investors about,ongoing and illegal ...
... Standardized ... Digital RSA Solution, ... IDL), the global leader in digital radiography (DR) for image,quality ... as the DR component for an imaging product suite currently,under ...
... study from the American Cancer Society finds that while breast ... U.S. state, for African American women, death rates are either ... study, published early online in the journal Cancer Causes and ... are decreasing in only 11 of 37 states with sufficient ...
... Dental Experts to Advance ... of CCLAD in Dentistry, LIVINGSTON, N.J., Feb. 28 ... leader in,advanced injection technologies, today reported that earlier this ... (CCLAD) Summit in New Orleans. The Summit welcomed a ...
... to unprotected, masochistic sex as adults , , THURSDAY, Feb. ... consequence of spanking: risky sexual behaviors, or even sexual ... one more harmful side effect to spanking," said Murray ... the findings of four studies at the American Psychological ...
... on March 17, 2008 at 10:00 a.m., FREEHOLD, ... NAHC ) will report financial results,for the fourth ... March,17, 2008 prior to market open., The Company ... March,17, 2008 at 10:00 a.m. Eastern Time (ET). Following ...
Cached Medicine News:Health News:Teamsters Warn of Possible Work Stoppages, Service Disruptions at AmerisourceBergen 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 2Health News:IDC X-Series DR system selected for use in leading edge RSA clinical trial application 3Health News:Breast cancer death rates among black women not decreasing across all states 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 2Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 3Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 4Health News:Milestone Scientific Hosts First International Computer-Controlled Local Anesthetic Delivery (CCLAD) Summit 5Health News:Spanking Raises Chances of Risky, Deviant Sexual Behavior 2Health News:Spanking Raises Chances of Risky, Deviant Sexual Behavior 3Health News:National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008 2Health News:National Atlantic Holdings Corporation to Report Fourth Quarter and Year-End 2007 Earnings on March 17, 2008 3
Intermittent catheter...
Intermittent catheter...
The SJM Sguin annuloplasty ring, a semi-rigid ring, is constructed of a one-piece solid core of ultra-high-weight polyethylene enclosed in a knitted polyester sewing cuff....
... Welcome to a new dimension ... a liquid tool composed of purified ... surgical capabilities. Perfluoron is ideal for ... vitreoretinopathy, giant retinal tears and trauma. ...
Medicine Products: